Serum GDF15 has been linked in recent research to the development of cancer and cardiovascular disease; however, there are still fewer studies examining the connection between serum GDF15 and T2DM in combination with MS, and the clinical application has not yet been promoted. Here, GDF15 is linked to cancer.